What’s New
Explore latest events, medical insights and trends.
Attenuating the atopic march: Meta Analysis of The Dupilumab Atopic Dermatitis Database for Incident Allergic Events
Read article
Rare diseases are more common than most people imagine
Rare Disease Day raises awareness for the 300 million people worldwide living with a rare disease, along with their families and carers. Over 6,000 rare diseases are characterized by a wide range of conditions and symptoms that can vary not only between diseases but also among individuals with the same condition. Take the opportunity to support equitable access to diagnosis, treatment, healthcare, social support for those affected by rare diseases.
Igniting Healthier Skin 2026: Event Highlight Recordings
The programme brought together international and local experts to discuss the evolving understanding of Type 2 inflammation in atopic dermatitis, with a focus on IL-4 and IL-13, disease modification, and the importance of early intervention across different patient populations.
United in RARE: Advancing LSDs Care Across ASIA
The United in Rare: Advancing LSDs Care across Asia event was held on the 22nd to 23rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.
Type 2 Asthma Remission: Latest Data
Nearly 1 in 3 patients with uncontrolled moderate‑to‑severe type 2 asthma achieved clinical remission with dupilumab. Our latest update highlights key QUEST/TRAVERSE data, remission criteria, and implications for practice.
LIBERTY AD CHRONOS (18+ years)
LIBERTY AD CHRONOS was a randomized, double-blind, placebo-controlled trial in adults with
moderate-to-severe atopic dermatitis
Request-form